Patents for A61P 3 - Drugs for disorders of the metabolism (129,789)
10/2010
10/13/2010EP2239272A2 Specific protein of the pancreatic beta cells of the Langerhans' islands and applications thereof
10/13/2010EP2239270A2 Low molecular weight peptide derivatives as inhibitors of the Laminin/Nidogen interaction
10/13/2010EP2239253A1 Novel phenylpyrrole derivative
10/13/2010EP2239012A2 Pharmaceutical use of substituted amides
10/13/2010EP2238987A1 Sugar chain-related gene and use thereof
10/13/2010EP2238970A1 Emulsion preparation for external application to skin and cosmetic preparation
10/13/2010EP2238969A1 Preparation for external application to skin and cosmetic preparation
10/13/2010EP2238126A2 Derivatives of tetrahydroquinoxaline urea, preparation thereof and therapeutic application thereof
10/13/2010EP2237779A1 Benzothiazole and benzoxazole derivatives and methods of use
10/13/2010EP2004658B1 Condensed imidazole derivatives as aromatase inhibitors
10/13/2010EP1902039B1 6-oxazol-4-ylmethoxy-alkoxymethyl substituted benzoic acid derivatives forming ppar ligands, methods for production and the use thereof in the form of drugs
10/13/2010EP1487967B1 Chimeric pancreas
10/13/2010CN1976691B Cysteamines for treating complications of hypercholesterolemia and diabetes
10/13/2010CN1972918B Pyrimidine derivatives
10/13/2010CN1931258B Preparation process and use of loquat seed extract
10/13/2010CN1927202B Vitamin E nicotinate microcapsule and its preparing process
10/13/2010CN1919207B Gariic and medlar capsule
10/13/2010CN1761465B Method for manufacturing coated formulation
10/13/2010CN1628829B Chinese medicine for treating hypertension, high blood fat and high blood sugar
10/13/2010CN1395581B Recombinant antibodies to human IL-1 beta
10/13/2010CN101861311A 5-pyridinone substituted indazoles
10/13/2010CN101861303A Glycogen phosphorylase inhibitor compound and pharmaceutical composition thereof
10/13/2010CN101861149A N-(2-thiazolyl)-amide derivatives for the treatment of obesity, diabetes and cardiovascular diseases
10/13/2010CN101857646A Method for extracting high-purity beta-glucan and whole oat flour from oat bran
10/13/2010CN101857642A Polysaccharide derivative and vanadium complex application thereof
10/13/2010CN101857636A Anti-interferon-alpha antibodies
10/13/2010CN101857594A Tetrahydropyridoindole compounds, and preparation method and application thereof
10/13/2010CN101857554A Cinamic compounds and derivatives therefrom for the inhibition of histone deacetylase
10/13/2010CN101857542A Method for manufacturing low-lead granular zinc citrate
10/13/2010CN101856471A Chinese medicinal composition for tonifying kidney and strengthening body
10/13/2010CN101856458A Chinese medicament for treating diabetes mellitus
10/13/2010CN101856450A Chinese medicinal composition for treating diabetic nephropathy
10/13/2010CN101856448A Chinese medicament for treating diabetes mellitus
10/13/2010CN101856439A Chestnutsdispe capsule and preparation method thereof
10/13/2010CN101856437A Chinese medicament for treating hyperlipidemia
10/13/2010CN101856433A Application of Puer tea in preparing dugs for preventing oxidative stress caused by immunosenescence or other relevant disease thereof
10/13/2010CN101856432A Preparation method of chitosan nanoparticles encapsulated tea polyphenol
10/13/2010CN101856405A Medicinal composition for treating type II diabetes mellitus and preparation method thereof
10/13/2010CN101856399A Application of white peony root extract in preparing medicament for treating diabetes mellitus
10/13/2010CN101856390A Slimming Chinese traditional medicament ointment
10/13/2010CN101856389A Chinese medicinal preparation for treating cardiovascular and cerebrovascular diseases and application thereof
10/13/2010CN101856383A Liver-protecting white spirit and preparation method thereof
10/13/2010CN101856382A Novel method for extracting and separating platycodin effective ingredients
10/13/2010CN101856369A Stachyose tablets for calcium supplementation and intestinal micro-ecological regulation
10/13/2010CN101856367A Preparation method of chicken bone paste zymolyte with antioxidant activity
10/13/2010CN101856354A Novel composition for reducing blood sugar
10/13/2010CN101856351A Composition and use thereof in preparation of RXR receptor transcription inhibitor
10/13/2010CN101856342A Pravastatin transdermal administration preparation and preparation method thereof
10/13/2010CN101856339A Controlled release dosage form and preparation method thereof
10/13/2010CN101597389B Mixture of momordica saponins and polysaccharides and extraction process and application thereof
10/13/2010CN101496580B Special diet and foodstuffs formula containing small peptide for diabetic
10/13/2010CN101491499B Composite liposome for injection containing 12 vitamins and preparation method thereof
10/13/2010CN101376016B Method for preparing Chinese medicine for treating hyperlipemia
10/13/2010CN101357156B Traditional Chinese medicine for curing diabetes and preparation method thereof
10/13/2010CN101258875B Yoghourt useful for lowering blood fat and preparation
10/13/2010CN101180047B Use of cyclodextrin complexes containing lipoic acid
10/13/2010CN101152233B Pharmaceutical composition of snakegourd fruit and folium ginkgo
10/13/2010CN101125882B Recombination PAC1 receptor agonist RMMAX and its expression method and application
10/13/2010CN101117630B Preparation method of nattokinase powder and natto Brazil mushroom capsule
10/13/2010CN101069557B Health-care blood-sugar-reducing food and preparing method
10/13/2010CN101041629B New process for the synthesis and new crystalline form of agomelatine and pharmaceutical compositions containing it
10/13/2010CN101007115B 'Qihong' oral liquid
10/12/2010US7812199 Hydroxyl compounds and compositions for cholesterol management and related uses
10/12/2010US7812169 Angiogenesis inhibitors; vision defects; anticancer agents; retinopathy; skin disorders; antiarthritic agents; antitumor agents; aids
10/12/2010US7812159 Processes for preparing aromatic ethers
10/12/2010US7812038 such as vascular cell adhesion molecules and fibronectins, administered for the treatment of asthma, multiple sclerosis or inflammatory bowel diseases in mammals; (3S)-3-{[({1-[(2-chlorophenyl)methyl]-4-hydroxy-2-oxo-1,2-dihydro-3quinolinyl}amino)carbonyl]amino}-3-(4-methylphenyl)propanoic acid
10/12/2010US7812004 For modifying and modulating the bacterial flora and the fermentation pattern of inulin in the large intestine; anticancer agents; dietary fibre effects, improved mineral absorption (calcium and magnesium), for treating osteoporosis
10/12/2010US7811816 Isolated CD8 +T lymphocytes specifically cytotoxic for a disease causing target cell
10/12/2010US7811573 Targetting dendritic cells, endothelial cells, and macrophages which express integrins, to induce maturation
10/12/2010CA2480038C Substituted 4-aminocyclohexanols
10/12/2010CA2445512C A method for treating or preventing a functional vitamin b12 deficiency in an individual and medical compositions for use in said method
10/12/2010CA2427352C Glycerophosphoinositol derivatives as modulators of cytosolic phospholipase
10/12/2010CA2410556C Konjac mannan and polysaccharide compositions and uses thereof
10/12/2010CA2407149C Melanin-concentrating hormone antagonist
10/12/2010CA2397964C Derivatives of partially desulphated glycosaminoglycans endowed with antiangiogenic activity and devoid of anticoagulating effect
10/12/2010CA2382317C Compounds, methods and pharmaceutical compositions for treating cellular damage, such as neural or cardiovascular tissue damage
10/12/2010CA2320402C Modified ciliary neurotrophic factor, method of making and methods of use thereof
10/07/2010WO2010114958A1 Bridged bicyclic heterocycle derivatives and methods of use thereof
10/07/2010WO2010114957A1 Bicyclic piperidine and piperazine derivatives as gpcr modulators for the treatment of obesity, diabetes and other metabolic disorders
10/07/2010WO2010114215A2 Composition for preventing or treating obesity, dyslipidemia, fatty liver or insulin resistance syndrome, comprising camphor as an active ingredient
10/07/2010WO2010113860A1 Biphenyl-cyclic amine compound
10/07/2010WO2010113841A1 Orally disintegrating coated tablet
10/07/2010WO2010113834A1 Pyrimidine compound
10/07/2010WO2010113785A1 Method for producing sugar composition containing definite amount of target hexose and having sugar composition ratio different from starting sugar material, and use of sugar composition thus produced
10/07/2010WO2010113631A1 Agent for amelioration or prevention of metabolic syndrome
10/07/2010WO2010112520A1 Spiro derivatives for the modulation of stearoyl-coa desaturase
10/07/2010WO2010112429A1 Reduction of risk of obesity
10/07/2010WO2010112256A1 Satiety-inducing composition
10/07/2010WO2010111905A1 Pharmaceutical composition for treatment of 2 type dabetes
10/07/2010WO2010111759A1 Stabiliser-free pharmaceutical compositions of tetrahydrolipstatin
10/07/2010WO2010091067A3 Derivatives of [1, 3] oxazin- 2-one useful for the treatment of metabolic diseases such as lipid disorders
10/07/2010WO2010088897A3 Plant extracts for regulating body weight
10/07/2010WO2010081862A3 Methods and preparations for protecting critically ill patients with a polyamine (e.g. spermine, spermidine)
10/07/2010WO2010079910A3 Eyesight-protecting composition containing functional components having preventive and therapeutic efficacy in diabetes or diabetes complications
10/07/2010WO2010059662A9 Constitutive androstane receptor (car) as a therapeutic target for obesity and type two diabetes
10/07/2010WO2010019435A3 Solid states of atorvastatin potassium
10/07/2010US20100256235 Dietary formulations and methods for treatment of inflammation and other disorders
10/07/2010US20100256220 PAS Kinase Regulates Energy Homeostasis
10/07/2010US20100256209 Compositions comprising ether compounds and pharmaceutical uses therefor
10/07/2010US20100256182 Substituted 1,2,3,4-tetrahydroisoquinoline derivatives